Peripheral neurotoxicity is the dose-limiting factor for clinical use of platinum derivatives, a class of anticancer drugs which includes cisplatin, carboplatin, and oxaliplatin. In particular cisplatin and oxaliplatin induce a severe peripheral neurotoxicity while carboplatin is less neurotoxic. The mechanisms proposed to explain these drugs' neurotoxicity are dorsal root ganglia alteration, oxidative stress involvement, and mitochondrial dysfunction. Oxaliplatin also causes an acute and reversible neuropathy, supposed to be due by transient dysfunction of the voltage-gated sodium channels of sensory neurons. Recent studies suggest that individual genetic variation may play a role in the pathogenesis of platinum drug neurotoxicity. Even though all these mechanisms have been investigated, the pathogenesis is far from clearly defined. In this review we will summarize the current knowledge and the most up-to-date hypotheses on the mechanisms of platinum drug-induced peripheral neurotoxicity.

Chiorazzi, A., Semperboni, S., Marmiroli, P. (2015). Current view in platinum drug mechanisms of peripheral neurotoxicity. TOXICS, 3(3), 304-321 [10.3390/toxics3030304].

Current view in platinum drug mechanisms of peripheral neurotoxicity

Chiorazzi, A
Co-primo
;
Semperboni, S
Co-primo
;
Marmiroli, P
Co-primo
2015

Abstract

Peripheral neurotoxicity is the dose-limiting factor for clinical use of platinum derivatives, a class of anticancer drugs which includes cisplatin, carboplatin, and oxaliplatin. In particular cisplatin and oxaliplatin induce a severe peripheral neurotoxicity while carboplatin is less neurotoxic. The mechanisms proposed to explain these drugs' neurotoxicity are dorsal root ganglia alteration, oxidative stress involvement, and mitochondrial dysfunction. Oxaliplatin also causes an acute and reversible neuropathy, supposed to be due by transient dysfunction of the voltage-gated sodium channels of sensory neurons. Recent studies suggest that individual genetic variation may play a role in the pathogenesis of platinum drug neurotoxicity. Even though all these mechanisms have been investigated, the pathogenesis is far from clearly defined. In this review we will summarize the current knowledge and the most up-to-date hypotheses on the mechanisms of platinum drug-induced peripheral neurotoxicity.
Articolo in rivista - Articolo scientifico
platinum drugs; peripheral neurotoxicity; mechanisms of action
English
2015
3
3
304
321
open
Chiorazzi, A., Semperboni, S., Marmiroli, P. (2015). Current view in platinum drug mechanisms of peripheral neurotoxicity. TOXICS, 3(3), 304-321 [10.3390/toxics3030304].
File in questo prodotto:
File Dimensione Formato  
toxics-03-00304-2.pdf

accesso aperto

Descrizione: articolo scientifico
Dimensione 419.1 kB
Formato Adobe PDF
419.1 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/91109
Citazioni
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 35
Social impact